INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo FLUCOL Tablets

SCHEDULING STATUS:
S2

PROPRIETARY NAME
(and dosage form):

FLUCOL Tablets

COMPOSITION:
Each tablet contains:
Paracetamol 150 mg
Codeine Phosphate 8 mg
Caffeine Anhydrous 30 mg
Mepyramine Maleate 10 mg
Phenylephrine HCl 5 mg
PHARMACOLOGICAL CLASSIFICATION:
A 5.8 Preparations for the common cold.

PHARMACOLOGICAL ACTION:
FLUCOL combines the antihistamine properties of mepyramine maleate, with the antitussive properties of codeine, the decongestant properties of phenylephrine, the antipyretic properties of paracetamol and the stimulant action of caffeine.

INDICATIONS:
Flu, common cold and sinusitis

CONTRA-INDICATIONS:
FLUCOL should be administered with caution to patients with hypertension, cardiac disorders, diabetes mellitus or peripheral vascular disease.

WARNINGS:
Do not use continuously for more than ten days without consulting your doctor. Patients suffering from liver or kidney disease should take FLUCOL under medical supervision.

DOSAGE AND DIRECTIONS FOR USE:
Adults: Two tablets every four hours.
Children 6-12 years: One tablet every four hours.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
The use of this medicine may lead to drowsiness which is aggravated by the simultaneous intake of alcohol.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Symptoms of overdosage include nausea and vomiting. Liver damage, which may be fatal, may only appear after a few days.

IDENTIFICATION:
An orange, blue and white mottled tablet.

PRESENTATION:
Packs of 1000 tablets.

STORAGE INSTRUCTIONS:
Store in a cool dry place.
KEEP OUT OF REACH OF CHILDREN

REFERENCE NUMBER:
B1485 (Act 101 of 1965)

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Pharmakon Manufacturing Laboratories CC
P.O. Box 47021
Parklands
2121

MARKETED AND DISTRIBUTED BY:
Acupharm (Pty) Ltd
43 Richards Drive
Halfway House
1685

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
25 November 1969. PB 1485/1000/1

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2004